375 related articles for article (PubMed ID: 38299237)
1. A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review).
Lempesis IG; Georgakopoulou VE; Reiter RJ; Spandidos DA
Int J Mol Med; 2024 Mar; 53(3):. PubMed ID: 38299237
[TBL] [Abstract][Full Text] [Related]
2. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
El-Missiry MA; El-Missiry ZMA; Othman AI
Eur J Pharmacol; 2020 Sep; 882():173329. PubMed ID: 32615182
[TBL] [Abstract][Full Text] [Related]
3. Pineal hormone melatonin as an adjuvant treatment for COVID‑19 (Review).
Vlachou M; Siamidi A; Dedeloudi A; Konstantinidou SK; Papanastasiou IP
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33576451
[TBL] [Abstract][Full Text] [Related]
4. Melatonin, aging, and COVID-19: Could melatonin be beneficial for COVID-19 treatment in the elderly?
Öztürk G; Akbulut KG; Güney Ş
Turk J Med Sci; 2020 Oct; 50(6):1504-1512. PubMed ID: 32777902
[TBL] [Abstract][Full Text] [Related]
5. Approaches towards fighting the COVID‑19 pandemic (Review).
Tsai SC; Lu CC; Bau DT; Chiu YJ; Yen YT; Hsu YM; Fu CW; Kuo SC; Lo YS; Chiu HY; Juan YN; Tsai FJ; Yang JS
Int J Mol Med; 2021 Jan; 47(1):3-22. PubMed ID: 33236131
[TBL] [Abstract][Full Text] [Related]
6. The Potential of Melatonin to Treat Atherosclerosis by Targeting Mitochondria.
Sun X; Chen L; Gui QJ
Curr Top Med Chem; 2023; 23(10):848-859. PubMed ID: 36650630
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological agents under investigation in the treatment of coronavirus disease 2019 and the importance of melatonin.
Parlakpinar H; Polat S; Acet HA
Fundam Clin Pharmacol; 2021 Feb; 35(1):62-75. PubMed ID: 32657483
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of melatonin in targeting molecular pathways of organ fibrosis.
Hosseinzadeh A; Pourhanifeh MH; Amiri S; Sheibani M; Irilouzadian R; Reiter RJ; Mehrzadi S
Pharmacol Rep; 2024 Feb; 76(1):25-50. PubMed ID: 37995089
[TBL] [Abstract][Full Text] [Related]
9. Melatonin as a putative protection against myocardial injury in COVID-19 infection.
Simko F; Hrenak J; Dominguez-Rodriguez A; Reiter RJ
Expert Rev Clin Pharmacol; 2020 Sep; 13(9):921-924. PubMed ID: 32893686
[No Abstract] [Full Text] [Related]
10. Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection.
Reiter RJ; Sharma R; Simko F; Dominguez-Rodriguez A; Tesarik J; Neel RL; Slominski AT; Kleszczynski K; Martin-Gimenez VM; Manucha W; Cardinali DP
Cell Mol Life Sci; 2022 Feb; 79(3):143. PubMed ID: 35187603
[TBL] [Abstract][Full Text] [Related]
11. The autonomic aspects of the post-COVID19 syndrome.
Dotan A; David P; Arnheim D; Shoenfeld Y
Autoimmun Rev; 2022 May; 21(5):103071. PubMed ID: 35182777
[TBL] [Abstract][Full Text] [Related]
12. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM
Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin.
Mehrzadi S; Karimi MY; Fatemi A; Reiter RJ; Hosseinzadeh A
Pharmacol Ther; 2021 Aug; 224():107825. PubMed ID: 33662449
[TBL] [Abstract][Full Text] [Related]
14. A review of melatonin in hepatic ischemia/reperfusion injury and clinical liver disease.
Li Y; Yang Y; Feng Y; Yan J; Fan C; Jiang S; Qu Y
Ann Med; 2014 Nov; 46(7):503-11. PubMed ID: 25033992
[TBL] [Abstract][Full Text] [Related]
15. Potential Therapeutic Approach of Melatonin against Omicron and Some Other Variants of SARS-CoV-2.
Begum R; Mamun-Or-Rashid ANM; Lucy TT; Pramanik MK; Sil BK; Mukerjee N; Tagde P; Yagi M; Yonei Y
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296527
[TBL] [Abstract][Full Text] [Related]
16. Possible Application of Melatonin in Long COVID.
Cardinali DP; Brown GM; Pandi-Perumal SR
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358996
[TBL] [Abstract][Full Text] [Related]
17. Role of melatonin in the treatment of COVID-19; as an adjuvant through cluster differentiation 147 (CD147).
Sehirli AO; Sayiner S; Serakinci N
Mol Biol Rep; 2020 Oct; 47(10):8229-8233. PubMed ID: 32920757
[TBL] [Abstract][Full Text] [Related]
18. COVID-19: Melatonin as a potential adjuvant treatment.
Zhang R; Wang X; Ni L; Di X; Ma B; Niu S; Liu C; Reiter RJ
Life Sci; 2020 Jun; 250():117583. PubMed ID: 32217117
[TBL] [Abstract][Full Text] [Related]
19. Current treatment strategies for COVID‑19 (Review).
Han F; Liu Y; Mo M; Chen J; Wang C; Yang Y; Wu J
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34664677
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Ziaei A; Davoodian P; Dadvand H; Safa O; Hassanipour S; Omidi M; Masjedi M; Mahmoudikia F; Rafiee B; Fathalipour M
Trials; 2020 Oct; 21(1):882. PubMed ID: 33106171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
